BrightInsight, Inc., provider of the leading global platform for biopharma and medtech regulated digital health solutions, announced today that the company has been named to Fierce Medtech’s 2022 Fierce 15. The Fierce Medtech’s Fierce 15 spotlights the most exciting startups in medtech.
“We are honored and excited to be named to Fierce Medtech’s 2022 Fierce 15 list and be among so many great innovators and startups in medtech,” said Kal Patel, M.D., CEO and Co-Founder of BrightInsight. “It was a hugely successful year for our company, made possible by the hard work, tenacity and dedication of our stellar team. And we expect 2023 to be an even bigger, better year. Digital has been maturing over the last five years—which has helped to drive adoption by biopharma and medtech. As we continue to invest in our BrightInsight platform and launch new products for our clients that deliver results, the future looks bright.”
Highlights from 2022 that made BrightInsight fierce:
- Two product launches: Our Disease Management Solution, a comprehensive suite of configurable digital applications to improve the treatment experience for patients and the Connected Diagnostics Platform, which enables IVD manufacturers to streamline workflows, drive innovation and help speed time to diagnosis.
- New customer wins announced with Sanofi and bioMérieux
- Expanded our engagement with CSL Behring with an enterprise agreement to build, launch and maintain digital solutions for its late-stage and marketed rare disease therapies
- Ranked 217th fastest growing company in North America on the 2022 Deloitte Technology Fast 500™ list.
- Launched the BrightInsight Ecosystem, a network of 20+ leading healthcare and technology companies collaborating to solve healthcare’s biggest challenges to drive digital innovation, adoption and engagement.
“The annual special report showcases the most exciting medtech startups. This year’s honorees have demonstrated innovative solutions and have the potential to make a big impact in both the tech and healthcare industries. We applaud them and wish them success,” said Ayla Ellison, editor-in-chief of Fierce Biotech, Fierce Pharma and Fierce Healthcare.
Visit AITechPark for cutting-edge Tech Trends around AI, ML, Cybersecurity, along with AITech News, and timely updates from industry professionals!
